Galapagos NV - ADR Stock, NASDAQ:GLPG
Industriepark Mechelen Noord, Generaal de Wittelaan L11 A3, Mechelen, Brussels Region 2800
Number of Employees: 1304
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.